Sarah Heeson

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

Sandra M. Swain, José Baselga, Sung‐Bae Kim et al. · New England Journal of Medicine · 2015 · 2.1K citations · Full text

Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops

Adele Murrell, Sarah Heeson, Wolf Reik · Nature Genetics · 2004 · 537 citations

Histone Modifications, Chromatin, Regions Partitions +12

An intragenic methylated region in the imprinted <i>Igf2</i> gene augments transcription

Adele Murrell, Sarah Heeson, Lucy Bowden et al. · EMBO Reports · 2001 · 149 citations · Full text

Histone Modifications, Chromatin, Transcriptional Regulation +15

Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study

Antoinette R. Tan, Seock‐Ah Im, André Mattar et al. · The Lancet Oncology · 2020 · 149 citations

Breast Oncology, Oncology, Pharmacology +6

Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy

Ander Urruticoechea, Mohammed Rizwanullah, Seock‐Ah Im et al. · Journal of Clinical Oncology · 2017 · 119 citations